3652 results for «331»
3652 results
Innovations in aortic valves
11 Sep 2025 – From PCR Rio Valves 2025
Discover the latest innovations in aortic valve technology in this comprehensive session. Explore initial clinical experiences with new self-expandable valves in small annuli, mid-term durability data of novel prostheses, and cutting-edge developments such as silver nanoparticle-coated valves and vascular protection implantable systems, providing a forward-looking perspective...
TAVI and structural imaging
11 Sep 2025 – From PCR Rio Valves 2025
This session addresses the critical role of structural imaging in TAVI procedures. Gain valuable knowledge on multimodal imaging approaches in TAVI-in-TAVI cases, complex paravalvular leak management, and unique complications after surgical valve replacement. The session also includes case studies highlighting combined treatments and challenges in severe...
Mitral TEER intraprocedural guidance
11 Sep 2025 – From PCR Rio Valves 2025
This session offers a detailed exploration of mitral TEER intraprocedural guidance through case-based learning. It highlights step-by-step techniques, including post-processing and key questions interventionalists face regarding residual regurgitation, clip insertion, and evaluating final procedural outcomes.
Minimalist approach to tricuspid valve therapy
11 Sep 2025 – From PCR Rio Valves 2025
This session highlights the minimalist approach to tricuspid valve therapy with TricValve implantation, a contrast-free, minimally invasive procedure guided by transthoracic echo and minimal fluoroscopy. Clinical evidence shows reduced hospitalisations, improved quality of life, and encouraging mid-term outcomes, including smaller right heart chamber dimensions and reduced...
Innovation session: new techniques and devices in Latin America
11 Sep 2025 – From PCR Rio Valves 2025
Join this innovation-focused session highlighting new structural heart devices and techniques emerging from Latin America. Review real-world cases including mechanical valve re-intervention, TMVR, novel mitral TEER devices, and first clinical experiences with a new self-expandable transcatheter aortic valve in small annuli. Gain valuable procedural and clinical...
Tricuspid and mitral: fine tuning diagnosis and results in transcatheter valve management
11 Sep 2025 – From PCR Rio Valves 2025
This session focuses on refining diagnosis and treatment outcomes in transcatheter management of tricuspid and mitral valves. Topics include assessment of pulmonary artery pressure changes post-MitraClip, 3D echocardiographic evaluation of tricuspid regurgitation severity, quantitative improvements in imaging, and insights from single-centre experiences. Additional discussions cover bicaval...
The complexity of transcatheter tricuspid valve interventions
11 Sep 2025 – From PCR Rio Valves 2025
Explore the complexities of transcatheter tricuspid valve interventions through a series of case studies tackling challenging clinical scenarios. Discover therapeutic options, including TEER in patients with pacemaker leads, imaging strategies with ICE, transcatheter tricuspid valve replacement using Evoque and LuxValve devices, as well as simpler approaches...
Management of hostile access for TAVI
11 Sep 2025 – From PCR Rio Valves 2025
Access challenges are among the most critical hurdles in TAVI procedures. This session explores how to identify difficult access routes using pre-procedural CT, and demonstrates practical techniques to safely overcome these obstacles. Through real-life case presentations—including challenging femoral access with a shockwave balloon, carotid access, and...
Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial
29 Mar 2025
Aaysha Cader provides her take on the ECLIPSE trial presented by Gregg W. Stone at ACC.25 in Chicago.
Author
UNIVERSAL: routine ultrasonography guidance for femoral vascular access for cardiac procedures - A randomized clinical Trial
19 Sep 2022
Ali Nazmi Calik provides his take on UNIVERSAL randomized clinical trial, which questioned whether routine ultrasonography guidance for CFA access for cardiac procedures reduces bleeding or vascular complications. This trial was presented by Sanjit S. Jolly during TCT 2022.
Author
REC-CAGEFREE I - Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of de novo coronary artery lesions
08 Sep 2024
Mirvat Alasnag provides her take on REC-CAGEFREE I, a multicenter, non-inferiority trial presented at the ESC Congress 2024 in London.
Author
Future directions of drug-coated balloon angioplasty
06 Feb 2025
Fernando Alfonso and Javier Cuesta discuss the growing role of drug-coated balloons as an alternative to stents in percutaneous coronary interventions. Highlighting advantages like reduced in-stent restenosis, they emphasize the need for robust clinical studies to refine DCB use.
Author
Author
